ERICA WESTBROOKS: Open Payments
NPI 1467703975 · DES PERES, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,029 in 233 payments from 23 companies in 2025. Trend: 2023 $4,098 · 2024 $4,185 · 2025 $6,029
Food & beverage: $4,757Speaker / faculty: $1,197Education: $75
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $1,635 |
| UCB, Inc. | 22 | $591 |
| ABBVIE INC. | 36 | $583 |
| Janssen Biotech, Inc. | 25 | $524 |
| Arcutis Biotherapeutics, Inc. | 23 | $444 |
| Incyte Corporation | 21 | $365 |
| Lilly USA, LLC | 9 | $294 |
| PFIZER INC. | 12 | $243 |
| Galderma Laboratories, L.P. | 21 | $224 |
| LEO Pharma Inc. | 7 | $218 |
Products named: DUPIXENT, Bimzelx, TREMFYA, Zoryve, OPZELURA, SKYRIZI, RINVOQ, CIBINQO.
Industry payments across MO — which companies pay providers there.
